secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2022-02-25T23:59:59+00:00
Accession:  0001193125-22-054600
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Compass Therapeutics director Brett Kaplan resigns from Board effective Feb 25, 2022
--------------------------------------------------------------------------------

- Brett Kaplan, M.D. resigned from the Board and all committees, effective February 25, 2022.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- No replacement announced; Board composition changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000119312522054600/0001193125-22-054600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000119312522054600/d289527d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-054600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer